ntipyrine and bromide dilution are frequently used to estimate total body water and extracelIular water volumes, respectively. We assessed a potential error with the simultaneous use of these methods. In vitro the bromide concentration of solutions measured by the gold chloride or rosaniline methods decreased linearly with increasing concentrations of antipyrine. With the gold chloride method, the "inhibitory" effect of antipyrine was more pronounced for solutions in plasma than in those in water. With the rosaniline method, the "inhibitory" effect was similar for water and plasma.
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Antipyrine had no effect on bromide concentration measured by fluorescein or fluorescence excitation methods. We conclude that antipyrine potentially affects the measurement of bromide space by certain colonmetric methods. The mean values of previously published data do not appear to have been affected by the technical problems described in this study, although these problems may account, at least in part, for the large variability of the results. 
laterlals and Methods
Two sets of solutions were prepared. The first set conained bromide (as sodium salt), 0.25 molJL, and antipyine, 0, 6.6, 13.3, 26.6, and 53 mmoIiL, dissolved in water. he second set contained bromide, 1.9 mmol/L, and antipyme, 0, 53, 106, 159, 212, and 266 mmol/L, dissolved in ooled human plasma obtained from heparinized cord blood serum from blood-bank donors should not be used because Each solution was separated into aliquots, which were stored at -15#{176} C until analyzed.
Bromide concentrations were determined in triplicate by three colorimetric methods: gold chloride (2), rosaniline (3), fluorescein (4, 5) , and fluorescence excitation analysis (6, 7) . Results of the gold chloride and rosaniline analyses were verified by repeated measurements in two laboratories. Microadaptations of the original methods were used.
The gold chloride method was adapted to assay plasma samples of 100 L. Reproducibility of the micromethod was determined by analyzing 15 aliquots of a solution on five different occasions. The intra-assay CV was 2.4-2.9%, the interassay CV was 6.2%, and the interlaboratory CV was 13.2%.
The rosaniline method was adapted to assay 5-L plasma samples. The intra-assay CV for four independent runs of 15 identical aliquots ranged from 3.5% to 6.8%, the interassay CV was 6.7%, and the interlaboratory CV was 4.7%. The fluorescein method was adapted to assay 20-L plasma samples. The intra-assay CV, calculated as the mean CV of triplicate determinations in 53 infants' sera containing bromide concentrations between 1.3 and 5.7 mmol/L, was 4.7%. The interassay CV, determined by performing the assay on the same three serum samples on six different days spaced over a six-month interval, was 6.3%.
The fluorescence excitation method was performed at the Radiologic Imaging Laboratory of the University of California, San Francisco, as described in detail elsewhere (6, 7) . Bromide was excited by photons emitted by a 2.5-mCi cyclotron-grade 109Cd source. The intra-assay CV for this method, calculated by analyzing five aliquots of an identical solution, was 1.4%. The interassay CV was not determined for this study but has been reported to be about 2% in that particular laboratory (6, 7) . Data were analyzed by regression analysis.
Results
Antipyrine had a marked effect on bromide concentration measured by the gold chloride and rosaniline methods. With the gold chloride method, the measured concentration of bromide in water solutions decreased by 8.5% for each 100 mol/L of antipyrine added (Figure 1, left) . The "inhibitory" effect of antipyrine was twice as great as in plasma solutions: there, the measured concentration of bromide decreased by 16.7-17.8% with each 100 moIJL of antipyrine added. With the rosaniline method, the presence of antipyrine had a less-pronounced but still significant effect on the measurement of bromide concentrations. The effect was of the same magnitude for water and plasma solutions. The measured concentration of bromide decreased by 5.8-6.8% with each 100 mol/L of antipyrine added (Figure 1 , right).
Antipyrine did not affect the bromide concentration of solutions measured by fluorescein or fluorescent excitation methods (Table 1) 
Discussion
These in vitro data clearly indicate that antipyrine interferes with certain colorimetric determinations of bromide concentrations in water or biological samples. This interference consists of an "inhibition" of the color development, and results in underestimation of the concentration of bromide in samples containing antipyrine. The chemical mechanism of this "inhibition" is not known. 
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Desiccation studies 397 (39) D20, deuterated water; PIXE, proton-inducedx-ray emission. between group means are likely to be valid if the same technique was used in studying the groups being compared.
In future studies of body water content and distribution, alternative methods should be used, to avoid the potential error introduced by the effect of antipyrine on bromide measurement. There is currently no alternative to using bromide as a marker for extracellular water in vivo, but alternatives to using antipyrine include deuterated water (11, 13, 17) and water enriched in (17) . Deuterium is not easy to measure in small amounts of plasma and, for serial human studies, it is not devoid of toxicity (18) . 180 is safe, even for frequently repeated uses (19) , but requires very expensive technology for its measurement. This expense, although justifiable for human studies, may be more difficult to justifr for animal experimentation.
A second alternative is to use bromide and antipyrine dilution sequentially. This increases the study time from 2 to 4 h and the number of blood samples needed from four to five, although the total amount of blood required for the study is not changed. These disadvantages do not significantly affect animal studies but may be less acceptable for human studies, especially in small neonates. A third alternative is to continue using antipyrine and bromide simultaneously, but to use methods of measuring bromide concentrations that are not affected by the presence of antipyrine. Possibilities include the fluorescein method (4, 5) or nuclear methods such as proton-induced x-ray emission (20) , neutron activation (21) , and fluorescence excitation (6, 7) .
